tradingkey.logo

Intelligent Bio Solutions Inc

INBS
6.140USD
-0.850-12.16%
收盤 12/19, 16:00美東報價延遲15分鐘
55.86M總市值
虧損本益比TTM

Intelligent Bio Solutions Inc

6.140
-0.850-12.16%

關於 Intelligent Bio Solutions Inc 公司

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Intelligent Bio Solutions Inc簡介

公司代碼INBS
公司名稱Intelligent Bio Solutions Inc
上市日期Dec 23, 2020
CEOSimeonidis (Harry)
員工數量16
證券類型Ordinary Share
年結日Dec 23
公司地址135 W 41St St,
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編10036
電話16467905756
網址https://ibs.inc/
公司代碼INBS
上市日期Dec 23, 2020
CEOSimeonidis (Harry)

Intelligent Bio Solutions Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United Kingdom
2.87M
93.96%
Rest of world
132.70K
4.35%
Australia
29.17K
0.96%
Americas
22.64K
0.74%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月15日 週六
更新時間: 11月15日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Alyeska Investment Group, L.P.
7.02%
Adar1 Capital Management LLC
4.44%
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.61%
Sakiris (Spiro Kevin)
0.56%
其他
86.34%
持股股東
持股股東
佔比
Alyeska Investment Group, L.P.
7.02%
Adar1 Capital Management LLC
4.44%
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.61%
Sakiris (Spiro Kevin)
0.56%
其他
86.34%
股東類型
持股股東
佔比
Hedge Fund
11.51%
Investment Advisor
1.33%
Individual Investor
0.99%
Investment Advisor/Hedge Fund
0.61%
Research Firm
0.14%
其他
85.42%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
31
799.23K
8.80%
-446.50K
2025Q2
34
836.82K
11.26%
+144.79K
2025Q1
36
981.28K
14.20%
+429.65K
2024Q4
38
214.35K
3.16%
-507.92K
2024Q3
38
390.00K
7.80%
-236.97K
2024Q2
42
449.42K
76.55%
-259.12K
2024Q1
46
732.30K
88.07%
+589.21K
2023Q4
40
172.56K
98.30%
+79.74K
2023Q3
42
49.64K
11.24%
+14.21K
2023Q2
43
60.27K
19.45%
+30.17K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Alyeska Investment Group, L.P.
613.89K
6.76%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
15.48K
0.17%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
51.45K
0.57%
+2.44K
+4.98%
Jun 30, 2025
Sakiris (Spiro Kevin)
53.93K
0.59%
--
--
Sep 11, 2025
Simeonidis (Harry)
40.41K
0.45%
--
--
Sep 11, 2025
Goldman Sachs & Company, Inc.
12.83K
0.14%
+10.00
+0.08%
Jun 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
公告日期
類型
比率
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1

常見問題

Intelligent Bio Solutions Inc的前五大股東是誰?

Intelligent Bio Solutions Inc的前五大股東如下:
Alyeska Investment Group, L.P.
持有股份:613.89K
佔總股份比例:6.76%。
The Vanguard Group, Inc.
持有股份:15.48K
佔總股份比例:0.17%。
Geode Capital Management, L.L.C.
持有股份:51.45K
佔總股份比例:0.57%。
Sakiris (Spiro Kevin)
持有股份:53.93K
佔總股份比例:0.59%。
Simeonidis (Harry)
持有股份:40.41K
佔總股份比例:0.45%。

Intelligent Bio Solutions Inc的前三大股東類型是什麼?

Intelligent Bio Solutions Inc 的前三大股東類型分別是:
Alyeska Investment Group, L.P.
Adar1 Capital Management LLC
The Vanguard Group, Inc.

有多少機構持有Intelligent Bio Solutions Inc(INBS)的股份?

截至2025Q3,共有31家機構持有Intelligent Bio Solutions Inc的股份,合計持有的股份價值約為799.23K,占公司總股份的8.80% 。與2025Q2相比,機構持股有所增加,增幅為-2.45%。

哪個業務部門對Intelligent Bio Solutions Inc的收入貢獻最大?

在FY2025,--業務部門對Intelligent Bio Solutions Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI